• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

Validation Data Gallery

Filter:
  • Western Blot (WB) analysis of various lysates using TRAF2 Recombinant antibody (84581-3-RR)

    WB analysis using 84581-3-RR (same clone as 84581-3-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 84581-3-RR (TRAF2 antibody) at dilution of 1:5000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Sandwich ELISA standard curve of MP01404-2

    Sandwich ELISA standard curve of MP01404-2

    Sandwich ELISA standard curve of MP01404-2, Human TRAF2 Recombinant Matched Antibody Pair - PBS only. 84581-3-PBS was coated to a plate as the capture antibody and incubated with serial dilutions of standard Ag25387. 84581-1-PBS was HRP conjugated as the detection antibody. Range: 3.13-200 ng/mL.

  • Sample test of MP01404-2

    Sample test of MP01404-2

    The mean TRAF2 concentration was determined to be 94.50 ng/mL in HeLa cell extract based on a 1.50 mg/mL extract load, 59.04 ng/mL in MOLT-4 cell extract based on a 1.20 mg/mL extract load, 25.97 ng/mL in PC-3 cell extract based on a 2.00 mg/mL extract load and 18.85 ng/mL in NIH/3T3 cell extract based on a 1.50 mg/mL extract load.

  • Immunohistochemistry (IHC) staining of human ovary cancer tissue using TRAF2 Recombinant antibody (84581-3-RR)

    IHC staining of human ovary cancer using 84581-3-RR (same clone as 84581-3-PBS)

    Immunohistochemical analysis of paraffin-embedded human ovary cancer tissue slide using 84581-3-RR (TRAF2 antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Immunohistochemistry (IHC) staining of human ovary cancer tissue using TRAF2 Recombinant antibody (84581-3-RR)

    IHC staining of human ovary cancer using 84581-3-RR (same clone as 84581-3-PBS)

    Immunohistochemical analysis of paraffin-embedded human ovary cancer tissue slide using 84581-3-RR (TRAF2 antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Immunohistochemistry (IHC) staining of human rectal cancer tissue using TRAF2 Recombinant antibody (84581-3-RR)

    IHC staining of human rectal cancer using 84581-3-RR (same clone as 84581-3-PBS)

    Immunohistochemical analysis of paraffin-embedded human rectal cancer tissue slide using 84581-3-RR (TRAF2 antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Immunohistochemistry (IHC) staining of human rectal cancer tissue using TRAF2 Recombinant antibody (84581-3-RR)

    IHC staining of human rectal cancer using 84581-3-RR (same clone as 84581-3-PBS)

    Immunohistochemical analysis of paraffin-embedded human rectal cancer tissue slide using 84581-3-RR (TRAF2 antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Immunofluorescence (IF) / fluorescent staining of HeLa cells using TRAF2 Recombinant antibody (84581-3-RR)

    IF Staining of HeLa using 84581-3-RR (same clone as 84581-3-PBS)

    Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using TRAF2 antibody (84581-3-RR, Clone: 241899A2 ) at dilution of 1:250 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2). This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Flow cytometry (FC) experiment of HeLa cells using TRAF2 Recombinant antibody (84581-3-RR)

    FC experiment of HeLa using 84581-3-RR (same clone as 84581-3-PBS)

    1x10^6 HeLa cells were intracellularly stained with 0.25 ug TRAF2 Recombinant antibody (84581-3-RR, Clone:241899A2) and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2)(red), or 0.25 ug Rabbit IgG Isotype Control RecAb (98136-1-RR, Clone: 240953C9) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C). This data was developed using the same antibody clone with 84581-3-PBS in a different storage buffer formulation.

  • Affinity and Kinetic Characterization of 84581-3-RR

    Affinity and Kinetic Characterization of 84581-3-RR

    Biolayer interferometry (BLl) kinetic assays of 84581-3-RR against Human TRAF2 were performed. The affinity constant is 0.544 nM.

［PR］まずは試したいあなたに。トライアルサイズも特別価格 >>『PRIME BUY抗体特割キャンペーン（4/21～）』

TRAF2 Recombinant antibody, PBS Only (Capture)

TRAF2 Uni-rAbTM Recombinant Antibody for WB, IHC, IF/ICC, FC (Intra), Sandwich ELISA, Indirect ELISA, Sample test
Cat No. 84581-3-PBS
Clone No.241899A2

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IHC, IF/ICC, FC (Intra), Sandwich ELISA, Indirect ELISA, Sample test

Synonyms

TRAP, TNF receptor-associated factor 2, RING-type E3 ubiquitin transferase TRAF2, EC:2.3.2.27, E3 ubiquitin-protein ligase TRAF2

Formulation:  PBS Only
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -

ご購入について

国内販売は「コスモ・バイオ株式会社」を通じて行っております。お見積り・ご注文はお近くの販売代理店へご連絡ください。

国内在庫・納期について

約2万点のプロテインテック製品をコスモバイオ社物流センター（国内）に在庫しています。国内在庫の有無はコスモバイオ社ホームページの「品番検索」でカタログ番号を検索して確認できます。

保証・サポートについて

テクニカルサポートまたはご購入後1年間の交換／補填対応を承ります。詳細はこちらをご覧ください。

Tested Applications

Recommended dilution

ApplicationDilution
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Product Information

84581-3-PBS targets TRAF2 as part of a matched antibody pair:

MP01404-2: 84581-3-PBS capture and 84581-1-PBS detection (validated in Sandwich ELISA)

Unconjugated rabbit recombinant monoclonal antibody in PBS only (BSA and azide free) storage buffer at a concentration of 1 mg/mL, ready for conjugation. Created using Proteintech’s proprietary in-house recombinant technology. Recombinant production enables unrivalled batch-to-batch consistency, easy scale-up, and future security of supply.

This conjugation ready format makes antibodies ideal for use in many applications including: ELISAs, multiplex assays requiring matched pairs, mass cytometry, and multiplex imaging applications.Antibody use should be optimized by the end user for each application and assay.

Tested Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen TRAF2 fusion protein Ag25387 相同性解析による交差性が予測される生物種
Full Name TNF receptor-associated factor 2
Calculated molecular weight 56 kDa
Observed molecular weight53 kDa
GenBank accession numberBC032410
Gene Symbol TRAF2
Gene ID (NCBI) 7186
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purfication
UNIPROT IDQ12933
Storage Buffer PBS only , pH 7.3
Storage ConditionsStore at -80°C.

Background Information

Tumor necrosis factor (TNF) receptor-associated factor-2 (TRAF2) is one of the members of the TRAF superfamily protein, which is an intracellular junction protein with E3 ligase activity. TRAF2 mediates and regulates the activation of nuclear factor kappa B (NF-κB) and microtubule-associated protein kinase (MAPK) signaling pathways by binding to TNFR family proteins. Recent studies have demonstrated that TRAF2 regulates tumor progression by through multiple pathways.